Literature DB >> 17425603

Expression of c-kit and Sca-1 and their relationship with multidrug resistance protein 1 in mouse bone marrow mononuclear cells.

Fernanda Kyle-Cezar1, Juliana Echevarria-Lima, Regina Coeli dos Santos Goldenberg, Vivian M Rumjanek.   

Abstract

P-glycoprotein (Pgp) and multidrug resistance protein 1 (MRP1) are members of the ATP-binding cassette (ABC) family of transporter proteins. Both molecules are membrane-associated, energy-dependent efflux pumps with different substrate selectivity and they may play a role in the activation, differentiation and function of haematopoietic cells. Mouse haematopoietic cells are characterized by the expression of the cell surface molecules c-kit and Sca-1. Herein, the presence and activities of Pgp and MRP1 in mouse bone marrow mononuclear cells (BMMC) and their relationship with the proteins c-kit and Sca-1 were evaluated. Pgp and MRP activities were measured based on the extrusion of rhodamine 123 (for Pgp) and Fluo-3 (for MRP). Cell populations were assessed by cytometry using anti-c-kit and anti-Sca1 antibodies. Pgp activity was present in 5% of BMMC while 50% of BMMC cells showed MRP activity. These findings agreed with the proportion of cells expressing the MRP1 surface molecule (51.3 +/- 4.17%). About 14% of BMMC were positive for c-kit and/or Sca-1 (9.3% c-kit- Sca-1+, 4.2% c-kit+ Sca-1- and 0.9% c-kit+ Sca-1+). Among these subpopulations only c-kit- Sca-1+ cells presented Pgp activity (21.36%). On the other hand, MRP activity was present in all three subpopulations. Most cells (82.5%) of the c-kit+ Sca-1- subpopulation presented MRP1 activity compared to only 54.1% of c-kit+ Sca-1+ and 38.8% of c-kit- Sca-1+. This study demonstrates the expression and activity of MRP1 in BMMC. While only a small proportion of precursor cells had Pgp activity, MRP1 activity was present among different subpopulations of precursor cells. Further studies are necessary to establish the role of these transporters in haematopoietic cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17425603      PMCID: PMC2265919          DOI: 10.1111/j.1365-2567.2007.02547.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  35 in total

1.  In vivo and in vitro modulation of MDR molecules in murine thymocytes.

Authors:  Daniela F P Leite; Juliana Echevarria-Lima; Leonardo T Salgado; Marcia A M Capella; João B Calixto; Vivian M Rumjanek
Journal:  Int Immunopharmacol       Date:  2005-08-30       Impact factor: 4.932

2.  Interleukin-6 production by activated human monocytic cells is enhanced by MK-571, a specific inhibitor of the multi-drug resistance protein-1.

Authors:  E Vellenga; L Tuyt; B J Wierenga; M Müller; W Dokter
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

Review 3.  Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.

Authors:  Elaine M Leslie; Roger G Deeley; Susan P C Cole
Journal:  Toxicol Appl Pharmacol       Date:  2005-05-01       Impact factor: 4.219

4.  Characterization of a population of cells in the bone marrow that phenotypically mimics hematopoietic stem cells: resting stem cells or mystery population?

Authors:  T D Randall; I L Weissman
Journal:  Stem Cells       Date:  1998       Impact factor: 6.277

5.  Expression of the multidrug resistance-associated protein (MRP) mRNA and protein in normal peripheral blood and bone marrow haemopoietic cells.

Authors:  O Legrand; J Y Perrot; R Tang; G Simonin; S Gurbuxani; R Zittoun; J P Marie
Journal:  Br J Haematol       Date:  1996-07       Impact factor: 6.998

6.  A multidrug-resistance protein (MRP)-like transmembrane pump is highly expressed by resting murine T helper (Th) 2, but not Th1 cells, and is induced to equal expression levels in Th1 and Th2 cells after antigenic stimulation in vivo.

Authors:  M Lohoff; S Prechtl; F Sommer; M Roellinghoff; E Schmitt; G Gradehandt; P Rohwer; B D Stride; S P Cole; R G Deeley
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

Review 7.  Substrate recognition and transport by multidrug resistance protein 1 (ABCC1).

Authors:  Roger G Deeley; Susan P C Cole
Journal:  FEBS Lett       Date:  2005-12-21       Impact factor: 4.124

8.  Multidrug transporter activity in lymphocytes.

Authors:  James I Elliott; Selina Raguz; Christopher F Higgins
Journal:  Br J Pharmacol       Date:  2004-10-18       Impact factor: 8.739

9.  A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels.

Authors:  G J Randolph; S Beaulieu; M Pope; I Sugawara; L Hoffman; R M Steinman; W A Muller
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

10.  Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.

Authors:  M A Goodell; K Brose; G Paradis; A S Conner; R C Mulligan
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

View more
  5 in total

1.  Inhibition of glycosphingolipid biosynthesis reverts multidrug resistance by differentially modulating ABC transporters in chronic myeloid leukemias.

Authors:  Eduardo J Salustiano; Kelli M da Costa; Leonardo Freire-de-Lima; Lucia Mendonça-Previato; José O Previato
Journal:  J Biol Chem       Date:  2020-03-30       Impact factor: 5.157

Review 2.  Cancer cell resistance mechanisms: a mini review.

Authors:  S Al-Dimassi; T Abou-Antoun; M El-Sibai
Journal:  Clin Transl Oncol       Date:  2014-03-20       Impact factor: 3.405

Review 3.  P-glycoprotein and drug resistance in systemic autoimmune diseases.

Authors:  Andrea Picchianti-Diamanti; Maria Manuela Rosado; Marco Scarsella; Bruno Laganà; Raffaele D'Amelio
Journal:  Int J Mol Sci       Date:  2014-03-20       Impact factor: 5.923

Review 4.  P-glycoprotein and chronic rhinosinusitis.

Authors:  Marcel M Miyake; Angela Nocera; Michelle M Miyake
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2018-08-24

5.  Stem cell factor induces polarization of microglia to the neuroprotective phenotype in vitro.

Authors:  Tomoya Terashima; Yuki Nakae; Miwako Katagi; Junko Okano; Yoshihisa Suzuki; Hideto Kojima
Journal:  Heliyon       Date:  2018-10-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.